
Linda Yaccarino
@lindayaX • 778,219 subscribers
CEO of eMed Population Health, Mom, foodie, fashion enthusiast, @penn_state alum, former CEO of X
Shorts
Videos

X is a mirror to the US. More than any other platform, we represent the ENTIRE country!
Linda Yaccarino27,080,775 görüntüleme • 1 yıl önce

GLP-1s are revolutionary drugs. Access isn't the problem. Affordability and adherence are. eMed scales access to GLP-1s at affordable pricing, so employers can finally cover them. AI plus clinical support. 90% adherence. Real outcomes. We're not a prescription pad. We're a support system.
Linda Yaccarino25,858 görüntüleme • 3 gün önce

The queen of pop culture, music, business, and TV is #Sliving on X. Paris Hilton welcome to the X family, we're excited to launch an official partnership with you and your next-gen media company 11:11. Together we're going to create a launchpad for new initiatives in video and live video, live commerce, Spaces, and so much more. Let's do this!!
Linda Yaccarino2,568,980 görüntüleme • 2 yıl önce

Honored to be at the The White House today as President Donald J. Trump signed the Take It Down Act. Grateful to First Lady Melania Trump for her dedication to ensuring safety. X will continue to work alongside Senator Ted Cruz Sen. Marsha Blackburn Rep. Nancy Mace and National Center for Missing & Exploited Children to do everything possible to make the internet safer, especially for children.
Linda Yaccarino286,992 görüntüleme • 1 yıl önce

There's a whole new vibe X and it was on display at yesterday's Client Council meeting thanks to our incredible teams! Kudos to our partners who participated. We revealed upcoming products, championed our creators (new announcements on the way) and reiterated our dedication to user protection, especially children. Shoutout to bluesky , Jim Rome , Nancy Lieberman, and Ice Cube who shared why they chose X. We're thrilled you're here. Two months in, and it's shaping up to be a transformational year!!
Linda Yaccarino529,403 görüntüleme • 2 yıl önce

GLP-1 programs need to be an investment. Not a cost. Leaders are being told the ROI crosses budget cycles. The data doesn't care about budget cycles. It's clear. Consistent. Irrefutable. Fight for it in the boardroom. Your employees' health matters much more than one budget cycle. eMed
Linda Yaccarino16,356 görüntüleme • 16 gün önce

1 in 10 people globally interact with AI weekly. 1 IN 8 AMERICANS ARE ON A GLP-1. Finally, healthcare DEFLATION. While AI is reshaping how we do things, GLP-1s are reshaping human biology. And their convergence offers something the US healthcare system has never experienced in its entire history. As Eric Larsen points out, this is not a trend. This is a restructuring of humanity. eMed
Linda Yaccarino19,193 görüntüleme • 24 gün önce

The shift is happening fast. AI. Personal health data. Patient engagement. Emerging medical evidence. The employers who recognize that GLP-1 medications have serious positive results to their workforce will get ahead of it. Thank you to my dear friend Arianna Huffington and Brooke Green for an engaging conversation. eMed
Linda Yaccarino23,271 görüntüleme • 1 ay önce

Last week on Fox Business with Maria Bartiromo, alongside Tom Brady, we announced our $200M Series A at a $2B+ valuation. We’re building how healthcare should actually work. For employers: better adherence, better outcomes, lower total cost. GLP-1s only work if people stay on them. We solve that at eMed. DMs open. 📩
Linda Yaccarino33,612 görüntüleme • 3 ay önce

A BIG moment for eMed. We've just raised $200M at a $2B+ valuation, and we're bringing on incredible investors and partners who believe deeply in what we're building. GLP-1s are one of the most powerful advances in medicine we've seen in humanity’s history . But they only work if people stay on them. We've built an empathic agentic AI platform that makes that happen, one that meets members where they are and guides them every step of the way. And the results speak for themselves. We're building the future of AI-powered population health. And we're just getting started. 🚀
Linda Yaccarino31,662 görüntüleme • 4 ay önce

When adherence is maintained with GLP-1 medications, health outcomes improve and financial outcomes follow. At eMed we are seeing a high adherence rate - the result of a structured program that drives results. Grateful to Arianna Huffington and Brooke Green of Aon for a conversation every employer needs to hear right now
Linda Yaccarino14,328 görüntüleme • 2 ay önce
Daha fazla içerik yok.




